Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8

PURPOSE: The purpose of this study is to test the ability of risedronate and estradiol, alone or in combination, to prevent bone loss associated with androgen deprivation therapy in men with prostate cancer. MATERIALS AND METHODS: This is a randomized placebo-controlled trial of risedronate and estr...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Kearns, Ann E., Northfelt, Donald W., Dueck, Amylou C., Atherton, Pamela J., Dakhil, Shaker R., Rowland, Kendrith M., Fuloria, Jyotsna, Flynn, Patrick J., Dentchev, Todor, Loprinzi, Charles L.
Format: Artigo
Sprog:Inglês
Udgivet: 2009
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3903398/
https://ncbi.nlm.nih.gov/pubmed/19468757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-009-0655-x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker